Navigation Links
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
Date:1/23/2008

CHESTER, N.J., Jan. 23 /PRNewswire/ -- Molecular Biometrics, a privately-held company developing novel diagnostic tools to more accurately characterize biologic function in health and disease, today announced that Denny Sakkas, Ph.D., Associate Professor, Yale University School of Medicine, and Director of the embryology laboratory at Yale Fertility Center, has joined the company as Chief Scientific Officer. Molecular Biometrics is applying its proprietary metabolomics technology to bring new accuracy to diagnostics in five areas of medicine where there is a demonstrated need, including reproductive health, neurodegenerative disease (Alzheimer's disease and Parkinson's disease), maternal fetal medicine, and drug discovery and development. The company's lead product candidates are diagnostic tests used to evaluate embryos, oocytes and sperm viability for in vitro fertilization (IVF).

Molecular Biometrics also announced that it is opening a new 2,200 square foot research facility, adjacent to Yale University, in January 2008. Dr. Sakkas will oversee the company's research and development activities from this new lab facility, which will initially be dedicated to the company's lead product candidate, ViaTest-E(TM). ViaTest-E is in late-stage development for the assessment of embryo viability in the field of IVF and assisted reproductive technology.

"Dr. Sakkas brings decades of research and clinical experience to our team. Denny is one of the top scientists in the field of embryology and has pioneered embryo culture, diagnosis and selection techniques, the analysis of cells to detect disease, and the development of tests for genetic disorders and chromosomal abnormalities," said James T. Posillico, PhD, President and Chief Executive Officer, Molecular Biometrics. "Denny will take on an integral role working with the company's scientific team to develop metabolomic-based diagnostic tools that offer more accurate, non-invasive methods for the embryol
'/>"/>

SOURCE Molecular Biometrics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
3. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
4. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
5. Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
7. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
10. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Amira Pharmaceuticals, Inc. announced today init... AM461, the Company,s second oral selective antago...,, The interim results demonstrate that a dose ...hieved with AM461. Additionally, AM461 Phase 1 da...461 is a back-up to Amira,s lead DP2 antagonist, A...
(Date:12/3/2009)..., India, December 3 Aditi,Technolo...pplication,development services, today announced i...ance to extend its services focus into Bioinformat...ing industry to leverage Aditi,s,superlative produ...st,practices know-how. , This alliance pr...
(Date:12/2/2009).../ -- Reportlinker.com announces that a new market..., Hospital Information Systems - A Global Updat...p://www.reportlinker.com/p0164256/Hospital-Informa...pportunities.html ,, Increasing awareness amon... Information Technology in the healthcare sector, ...
Breaking Medicine Technology:Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 8Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 1Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 2Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 3Keryx Biopharmaceuticals Inc To Present at the Rodman 26 Renshaw Annual Global Investment Conference and To Hold Investor Analyst Day 55700 4The Breema Center Presents Its Fall Week Long Intensive on Giving and Receiving Breema Bodywork 55697 1The Breema Center Presents Its Fall Week Long Intensive on Giving and Receiving Breema Bodywork 55697 2Genetic Clues May Lead to New Skin Cancer Therapies 55695 1Genetic Clues May Lead to New Skin Cancer Therapies 55695 2
...X), a,biopharmaceutical company specializing in de... Lipoprotein (HDL), often called,"good cholesterol...is of the Phase I/II Clinical Trial of its lead pr...ment of dyslipidemia and,heart disease. , A detail...l,blood chemistry and blood pressure measurements ...
...PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, ... data at the Annual Meeting,of the American Associ...14-18, 2007 in Los Angeles, California. , Data bei...-clinical data on SNS-032, a highly selective and ...) 2, 7 and 9 that is,currently in a Phase 1 clinic...
Other Medicine Technology:Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3Sunesis Pharmaceuticals to Present Data at the Annual Meeting of,the American Association for Cancer Research 2
(Date:12/3/2009)...These compulsive users also feel depressed or anxi... (HealthDay News) -- A survey of Chinese adolescen...et are twice as likely to harm themselves as other... to 18 who were living in the Chinese city of Guan...cent said they had harmed themselves in some way w...
(Date:12/3/2009)..., , Unfair Labor Practices, Protecting Do...PHIA, Dec. 3 Teamsters ...s facilities in Philadelphia went on strike this m...ems with working conditions at these facilities th...grity of the blood supply, not to mention the well...
(Date:12/3/2009)... The Lifestyle Advisors a...Spa Gifts to ease the stress of finding that perfe...ed the DIY treatments in health, fitness and welln...home on time and within budget. , ...season mySpaShop (mSS), has gathered an assortme...
(Date:12/3/2009)... Insightra Medical, Inc, ...nounced the launch of its new ventral hernia repai... standard sublay technique, which completely obvia...ring. , (PRWEB) December ...sed medical device company today announced the lau...
(Date:12/3/2009)..., , YOUNGTOWN, Ariz., Dec. 3 /PRNewswire...SG ), announced today that it has acquired SunView...heimer,s campus in Youngtown, Arizona, a sister co...community. The acquisition was effective December ...-bin/prnh/20071213/LATH168LOGO ) ,, "We are pl...
Breaking Medicine News(10 mins):Health News:Teen Internet Addicts More Likely to Self-Harm: Study 2Health News:Philadelphia Red Cross Blood Workers Strike to Protect Donor and Blood Safety 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 2Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 3Health News:Insightra Medical Launches the Freedom(TM) Ventral Hernia Repair, an Innovative New Way to Deploy Sublay Implants for Ventral Hernias Without Suturing 4Health News:The Ensign Group Acquires Arizona Skilled Nursing Facility 2
...N.C., April 23 Reynolds,American Inc. (NYSE: RAI...release of first-quarter 2008 financial results on...9:30 a.m. Eastern Time., During the call, members...y basis,at http://www.ReynoldsAmerican.com . Regi...
...l Meeting, WASHINGTON, April 23 Medical device i...ls will gather for the 2008,Annual Meeting of the ...,June 12th and 13th at the Marriott at Metro Cente...echnology,companies. The Annual Meeting brings lea...
... U.K. and Philadelphia, PA April 23, 2008 Shire p...y biopharmaceutical company, today announced that ...ug Administration (FDA) for VYVANSE (lisdexamfetam...f ADHD in children aged 6 to 12 years, is now the ...
...Program Addresses the Nursing Shortage By Supporti...ms, WASHINGTON, April 23 The Robert Wood Johnson... Colleges of Nursing,(AACN) announced today the cr...ine of students in accelerated nursing,programs. S...
..., April 23 Kaiser Permanente has,announced the pr...nia,Member Service Call Centers. Ward previously s...Centers. She joined Kaiser Permanente in 1988., I...ude more than 700 employees answering a wide varie...
...e., April 23 West Coast Bank,has committed $5,000...mote,the organization,s Guardian of Courage Event ...arol Grant, West Coast Bank Relationship Manager a... Children,s Cancer,Association sponsorship will pr...
Other Medicine News:Health News:RAI to Webcast First Quarter 2008 Earnings Conference Call 2Health News:Key Industry and Government Officials to Address Medical Technology Executives 2Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 2Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 3Health News:FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults 4Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 2Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 3Health News:Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program 4Health News:Trenita Ward Named Vice President, California Member Service Call Centers for Kaiser Permanente 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: